James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

A newly published benchmark dataset is helping push variant detection [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

Ethris has dosed the first patient in a Phase 2a [...]

Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

New natural language capability aims to reduce barriers for researchers [...]

No-code platform opens early access to generative binder design with [...]

New AI platform designed to support faster discovery, better study [...]